Jyothy Labs Q1 profit declines 45.9%
Jyothy Labs reportes a 45.9% decline in profit for the quarter ended June even as net sales declined 14.9% to Rs385.04 crore03-08-2017
03-08-2017
Press Release
Attached herewith is the copy of Press Release and Presentation on the Company's performance for the quarter ended June 30, 2017.03-08-2017
Financial Results For The Quarter Ended 01.06.2017
Outcome of Board meeting held on August 3, 2017 which commenced at 12.00 noon and concluded at 1.00 p.m along with the Un-audited Standalone and Consolidated Financial Results and Limited Review Report by the Statutory Auditors of the Company for the quarter ended June 30, 201703-08-2017
Intimation Of Schedule Of Earnings Call For Analyst(S) Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Company is organizing a quarterly earnings call for Analyst(s) at 4.00 p.m. on Thursday, August 3, 2017, subsequent to declaration of its Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2017 with Limited Review by the Statutory Auditors of the Company to discuss the Company's...27-07-2017
Intimation Of Schedule Of Earnings Call For Analyst(S) Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Pursuant to Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Company is organizing a quarterly earnings call for Analyst(s) at 4.00 p.m. on Thursday, August 3, 2017, subsequent to declaration of its Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2017 with Limited Review by the Statutory Auditors of the Company to discuss the Company's...27-07-2017
Board Meeting On August 3, 2017
Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, notice is hereby given that a Meeting of the Board of Directors of Jyothy Laboratories Limited (hereinafter referred to as 'the Company') is scheduled to be held on Thursday, August 3, 2017, inter-alia, to consider and approve Unaudited Standalone and Consolidated Financial Results of the Company with limited review by the Statutory Auditors of the Company.20-07-2017
Shareholding for the Period Ended June 30, 2017
Jyothy Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2017. For more details, kindly Click here17-07-2017
Statement Of Investor Grievances For The Quarter Ended June 30, 2017
Statement of Investor Complaints pursuant to Regulation 13(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201513-07-2017
Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Jyothy Laboratories Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here13-07-2017
Outcome of AGM
Voting results in respect of resolutions proposed in the Notice dated May 18, 2017 convening the 26th Annual General Meeting (AGM) of the Company held on July 11, 2017 in pursuance of Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations)12-07-2017